Medicure Inc.
MPH.V - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$31.1M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $31.10 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.68 |
| Beta | 1.15 |
| Outstanding Shares | 10,436,313 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -4.2 |
|---|---|
| PEG | -5.15 |
| Price to Sales | 1.47 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.09
Consensus analyst estimateRevenue Estimate
$4.64 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 19, 2026
EPS Estimate
$-0.04
Consensus analyst estimateRevenue Estimate
$6.48 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Medicure Inc.
23 employees
CEO: Albert David Friesen
Medicure Inc. operates as a biopharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the cardiovascular market, primarily serving Canada and the United States. Among its key off...